1 888 373 0881
Tel +1 (250) 655-5800
Fax +1 (250) 655-5811 firstname.lastname@example.org
AXYS Analytical Services Ltd.
2045 Mills Road W.
Sidney BC Canada
V8L 5X2 Map
AXYS Analytical Services continually champions product leadership in analytical chemistry, from its origins in chemistry and oceanography (see Origins below), to its everyday focus on evolving client needs and collaboration:
2011 AXYS expands the matrices tested by the PPCP and Alkylphenol methods to include tissues.
2010 AXYS continues to expand analysis of samples collected using passive samplers, including the analysis of Polar Organic Chemical Integrative Sampler (POCIS) for Naphthenic Acids, Acid Extractable Herbicides, Glyphosate, Carbamates and Hormones and Semipermeable Membrane Device (SPMD) sample analysis of PAH and alkylated PAHs.
2009 AXYS worked with the US EPA to expand EPA Method 1694 for PPCPs from 73 targets to 119.
2009 AXYS expands multiple tests to include additional matrices. These include the parabens method for biosolids and the Pharmaceutical and Personal Care Product and Alkylphenol methods for tissues.
2008 AXYS completes validation of a method to analyze ambient air for PFCs.
2008 AXYS jointly hosts the 10th Brominated Flame Retardant Meeting with the Institute of Ocean Sciences, Fisheries and Oceans Canada, Sidney, BC.
2007 AXYS provides expertise and technological support to the United States Environmental Protection Agency (US-EPA) to develop EPA Method 1698 for GC-MS analysis of sterols and hormones, EPA Method 1699 for the HR GC/MS analysis of current use pesticides and EPA Method 1694 for the LC-MS/MS analysis of PPCPs.
2006 AXYS offers Pharmaceutical and Personal Care Product (PPCP) analysis in aqueous and solid samples. This method became the basis for the US EPA Method 1694.
2005 AXYS provides technological support and reference data to the United States Environmental Protection Agency (US-EPA) to standardized comparability of sediment dioxin and PCB “field detection” approaches (SITE Study).
2005 AXYS first offers commercial analysis of Bisphenol-A in human serum and urine and Phthalate Ester Metabolites in urine by LC-MS/MS.
2004 AXYS customizes LR GC-MS analyses for low-level, congener-specific contaminant PCBs in human blood and fish tissue
2003 AXYS provides technological support and data to the United States Environmental Protection Agency (US-EPA) to establish HR GC-MS analysis of congener-specific Polybrominated diphenylethers (Method 1614 Draft), applied to multiple matrices.
2003 AXYS provides expertise and technological support to the US-EPA to update HR GC-MS analysis of 209 congener-specific PCBs (Method 1668A 2003), applied to multiple matrices.
2002 AXYS first offers commercial analysis of perfluorinated chemicals in environmental matrices.
2001 AXYS develops and offers commercial analysis of Brominated Dioxins and Furans to characterize samples from the World Trade Center site.
1999 AXYS provides expertise and technological support to the United States Environmental Protection Agency (US-EPA) to develop methodology for HR GC-MS analysis of all 209 PCB congeners in multiple matrices.
1997 World Health Organization European Regional Office recognizes AXYS Analytical as the only laboratory meeting its criteria for both human blood and milk analysis for dioxins, furans and dioxin-like PCBs.
1996 AXYS develops and offers commercial analysis of OrganoChlorine Pesticides in by GC high-resolution mass spectrometry in sediments and tissues.
1995 AXYS develops and offers commercial analysis of congener-specific Polybrominated Diphenyl Ethers (PBDE) by GC high-resolution mass spectrometry in water.
1995 Detection limit for dioxins in air samples first lowered to femtogram per litre (1 x 10-15) concentration range.
1992 AXYS offers commercial analysis of all 209 congener PCBs by GC high-resolution mass spectrometry including human serum and milk samples.
1991-96 AXYS data from samples of Distant Early Warning Line (DEW Line) remediation sites lays the foundation for the occurrence and persistence theories of Arctic PCBs.
1991 AXYS is the first commercial laboratory to offer analysis and characterization of coplanar PCBs by GC high-resolution mass spectrometry.
1988 AXYS Analytical is ranked first amongst labs for analysis of Dioxins and furans by Canadian government inter-laboratory study.
AXYS Analytical has its early roots in marine chemistry and oceanography. Its forerunner, Seakem Oceanography, was established in Victoria, British Columbia to provide oceanographic consulting primarily to Government of Canada in 1974. Seakem began chemical analysis in 1978 via its Arctic Laboratories division in Inuvik, Northwest Territories supporting oil and gas exploration. All operations were consolidated at Sidney, British Columbia in 1984 to serve the growing Canadian and US environmental markets.
While inorganic and trace metal analysis was still conducted in Sidney (ultimately leading to Seastar Chemicals Inc. establishment in 1987), Arctic Laboratories increasingly focused on trace organic chemical analysis and developed into Seakem Analytical. This specialization soon established leading analyses for pesticides and polycyclic aromatic hydrocarbons (PAHs), and a number of commercial ‘firsts’, including the first commercial congener specific analysis of polychlorinated biphenyls (PCBs) in 1986 and of dioxins (1988). The scope of matrices analyzed was also expanding beyond water and sediment, to include tissues and solid phase resins, such as XAD. The latter offered significant advances in detection limits using advanced high volume water sampling proprietary instrumentation, such as INFILTREX.
By 1990, it was clear that Seakem Oceanography’s various operational divisions had evolved into specific, functional entities. Seakem reorganized itself to become the AXYS Group of Companies, including AXYS Technologies Inc., AXYS Environmental Consulting Ltd., Seastar Chemicals Inc. and the specialty organic analytical lab, Seakem Analytical, became today’s AXYS Analytical Services. By the early 2000’s, all these entities were stand-alone companies, linked together by common shareholders and, most importantly, a proud reputation for leadership in their fields of expertise.